SCHEMBL18747634

SCHEMBL18747634

O=S(=O)(O)CCNC1CC=CCC1

nearest known ligand 0.31

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
CA14 Q9ULX7 1/20 0.31
NFE2L2 Q16236 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18747636 0.87 NFE2L2 (0.33) NFE2L2
SCHEMBL6904321 0.82 CA1 (0.32) CA1CA2CA7CA9CA14
SCHEMBL5483647 0.81 CA12 (0.35) CA7CA14NFE2L2
SCHEMBL18747676 0.77 KDM4E (0.39) CA1CA2CA7CA9CA14
SCHEMBL18747653 0.77 S1PR4 (0.36) CA1CA2CA7CA14NFE2L2
SCHEMBL18747702 0.76 KDM4E (0.42) CA1CA2CA7CA9CA14
SCHEMBL15919408 0.76 SPHK1 (0.35)
SCHEMBL161732 0.76 KDM4E (0.42) CA1CA2CA7CA9CA14
SCHEMBL18747649 0.76 KDM4E (0.42) CA1CA2CA7CA9CA14
SCHEMBL18747671 0.76 KDM4E (0.42) CA1CA2CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10509314-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2019-12-17 US disclosed
US-20170108774-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-04-20 US disclosed
US-20170108774-A1 RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10509314-B2 Resist composition and patterning process SRMS, SLC11A2, PCNA CA1 2190/4885CA2 3606/4885CA7 1764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.